Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
The offering, managed by BriaCell Therapeutics Corp (NASDAQ:BCTX) shares are trading lower by 40% to 65 cents Thursday afternoon after the company announced the pricing of a $5.5 million public offering of 7.4 million shares at 75 cents per share.
BriaCell Therapeutics Corp (納斯達克:BCTX)的股票在週四下午交易下跌40%，跌至65美分，原因是該公司宣佈以每股75美分的價格，進行740萬股的550萬美元公開發行。
What Else: BriaCell has priced an underwritten public offering of 7.4 million common shares and warrants at 75 cents per share and associated warrant.
其他消息：BriaCell已以每股75美分的價格，爲740萬普通股和Warrants定價，連同相關的Warrants。
The warrants, exercisable at $0.9375 per share for five years, accompany the shares in the offering, which is expected to generate gross proceeds of approximately $5.55 million before expenses.
這些Warrants的行使價爲每股0.9375美元，有效期爲五年，將與公開發行的股票共同進行，預計在扣除費用前將產生約555萬美元的毛收入。
The offering, managed by ThinkEquity, is set to close on December 13, pending customary conditions. BriaCell says the company plans to use the funds for working capital, corporate purposes and advancing its business goals.
此次由ThinkEquity管理的公開發行計劃於12月13日結束，需滿足慣例條件。BriaCell表示，公司計劃將這些資金用於流動資本、公司用途以及推進其業務目標。
Read Also: Stocks Fall As Producer Inflation Spikes, Jobless Claims Jump: 'What Is Happening Here?'
另見：股票下跌，生產者通脹激增，失業申請激增：『這裏發生了什麼？』
According to data from Benzinga Pro, BCTX has a 52-week high of $5.93 and a 52-week low of $0.46.
根據Benzinga Pro的數據，BCTX的52周最高價爲5.93美元，52周最低價爲0.46美元。
譯文內容由第三人軟體翻譯。
